ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat esophageal cancer
Disease control Not yet recruitingThis study is testing whether a new drug called QLC5508 works better than standard chemotherapy for people with advanced esophageal cancer that has continued to grow despite previous treatments. It will involve 466 adults whose cancer has spread and who have already tried platinu…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for stubborn esophageal cancer: radiation boost added to drug combo
Disease control Not yet recruitingThis study tests whether adding low-dose radiation to immunotherapy and chemotherapy before surgery helps patients with esophageal squamous cell carcinoma who didn't respond well to previous treatment. About 48 participants will receive radiation followed by two cycles of drug tr…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Triple-Threat attack on esophageal cancer before surgery
Disease control Not yet recruitingThis study is testing a new pre-surgery treatment for patients with a type of esophageal cancer that can be removed by surgery. It combines a short course of radiation with an immunotherapy drug (serplulimab) and two chemotherapy drugs. The goal is to shrink the tumor as much as …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Fluorescent dye guides surgeons in bid to prevent deadly leaks after cancer removal
Disease control Not yet recruitingThis study is testing a new surgical technique designed to lower the risk of dangerous leaks where the stomach is reconnected to the esophagus after cancer removal. It will involve 73 adults with esophageal cancer undergoing a specific type of minimally invasive surgery. The tech…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Major cancer trial aims to boost surgery success with powerful new drug combo
Disease control Not yet recruitingThis study is testing whether a new combination of drugs given before surgery works better than the current standard treatment for advanced esophageal cancer. About 390 patients with operable cancer will be randomly assigned to receive either the new treatment (toripalimab plus c…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New protocol aims to seal dangerous holes in cancer Patients' esophagus
Disease control Not yet recruitingThis study is testing a standardized treatment plan for a serious complication called an esophageal fistula, which is a hole that can form in the esophagus of patients with advanced esophageal cancer. The plan involves sealing the hole with a stent, treating infections, providing…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for esophageal cancer: extra drug after chemo and radiation?
Disease control Not yet recruitingThis study is for people with advanced esophageal cancer that cannot be surgically removed. After completing initial treatment with chemotherapy, immunotherapy, and radiation, patients whose cancer is stable or shrinking will be randomly assigned to either receive an extra immuno…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Scientists map esophageal Cancer's hidden journey
Knowledge-focused Not yet recruitingThis study aims to understand how esophageal cancer changes over time by tracking patients through blood tests, imaging scans, and tissue samples. Researchers will follow 255 people with esophageal cancer who are either recovering from surgery or receiving immunotherapy treatment…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC